The committee of Sun Pharma Advanced Research has allotted 8,64,034 equity shares of Re 1 each to the bondholders of SPIL upon exercise of option of conversion for 14,000 zero coupon FCCBs of $1000 each (FCCB) of SPIL held by them.
Consequently, the paid up equity share capital of the company has increased from Rs 19.95 crore to Rs 20.03 crore.
These shares were allotted at the committee meeting held on 20 October 2007.
Sun Pharma Advanced Research Company reported net loss of Rs 9.95 crore in Q1 June 2007 as compared to the net loss of Rs 4.98 crore in Q1 June 2006. There were no sales reported during Q1 June 2007.
The company is engaged in research, development and market pharmaceutical preparations, drugs and drug delivery systems.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment